Search Results 1351-1360 of 18303 for Topical

1. A Study of Using Palbociclib Combined with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive/ Human Epidermal Growth Factor Receptor 2 Negative Early Breast Cancer - Mayo Clinic

   Receiving concurrent exogenous hormone therapy (topical vaginal estrogen therapy is allowable). Participating Mayo Clinic locations. Study statuses change ...

2. A Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD Patients - Mayo Clinic

   ... topical steroids), or any medication that may cause cataract, according to the Prescribing Information. The patient has received strong or moderate inducers ...

3. Trial of Intravesical Measles Virotherapy in Patients With Bladder Cancer Who Are Undergoing Radical Cystectomy - Mayo Clinic

   Inhaled or topical steroids, and adrenal replacement doses > 10 mg daily prednisone equivalents are permitted in the absence of active autoimmune disease.

4. IFX_HU2.0 As An Adjunctive Therapy To Pembrolixumab In Checkpoint Inhibitor Naive Subjects With Advanced Or Metastatic Merkel Cell Carcinoma - Mayo Clinic

   Inhaled or topical steroids are permitted in the absence of active autoimmune disease. Note: Other protocol defined Inclusion/Exclusion Criteria may apply ...

5. Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors - Mayo Clinic

   Participation eligibility · Adrenal replacement (dose of ≤10 mg daily of prednisone or equivalent); · Topical, ocular, intra-articular, intranasal, or ...

6. Cough Clinic employs novel pharmacologics to address unexplained or refractory chronic cough - Mayo Clinic

   We often consider using a topical anesthetic such as a tetracaine lollipop, a formulation that was developed at Mayo Clinic that is compounded at Mayo ...

7. Chemoradiation With or Without Atezolizumab in Treating Patients With Limited Stage Small Cell Lung Cancer - Mayo Clinic

   Inhaled or topical steroids and adrenal replacement doses > 10 mg daily prednisone equivalents are permitted in the absence of active autoimmune disease.

8. A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030) - Mayo Clinic

   Disease is well controlled at baseline and requires only low-potency topical corticosteroids;; No occurrence of acute exacerbations of the underlying ...

9. A Study Evaluating AMG 424 in Subjects With Multiple Myeloma - Mayo Clinic

   Use of topical or inhaled steroids is acceptable. Anticancer treatment (chemotherapy, IMiD, PI, molecular targeted therapy) < 2 weeks prior to study Day 1 ...

10. RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC - Mayo Clinic

    Conditions requiring treatment with immunosuppressive medications within 30 days. Inhaled or topical steroids, and adrenal replacement steroid dose are ...